← Open Payments lookup

STEPHANIE O'MALLEY: Open Payments

NPI 1366177420 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,196 in 149 payments from 23 companies in 2025. Trend: 2023 $3,901 · 2024 $3,646 · 2025 $3,196

Food & beverage: $3,124Education: $73
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$620
Teva Pharmaceuticals USA, Inc.17$371
E.R. Squibb & Sons, L.L.C.11$329
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$283
Otsuka America Pharmaceutical, Inc.14$265
Vanda Pharmaceuticals Inc.10$228
Lundbeck LLC20$225
Alkermes, Inc.11$197
Axsome Therapeutics, Inc.5$120
Bausch Health US, LLC4$90

Products named: INGREZZA, REXULTI, COBENFY, CAPLYTA, AUSTEDO XR, FANAPT, ARISTADA, REJOYN.

Industry payments across NY — which companies pay providers there.